These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 17725751

  • 1. Effect of end-stage renal failure and hemodialysis on mortality rates in implantable cardioverter-defibrillator recipients.
    Hreybe H, Razak E, Saba S.
    Pacing Clin Electrophysiol; 2007 Sep; 30(9):1091-5. PubMed ID: 17725751
    [Abstract] [Full Text] [Related]

  • 2. Survival and appropriate device interventions in recipients of cardioverter defibrillators implanted for the primary versus secondary prevention of sudden cardiac death.
    Stockburger M, Krebs A, Nitardy A, Habedank D, Celebi O, Knaus T, Dietz R.
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S16-20. PubMed ID: 19250084
    [Abstract] [Full Text] [Related]

  • 3. Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death.
    Cuculich PS, Sánchez JM, Kerzner R, Greenberg SL, Sengupta J, Chen J, Faddis MN, Gleva MJ, Smith TW, Lindsay BD.
    Pacing Clin Electrophysiol; 2007 Feb; 30(2):207-13. PubMed ID: 17338717
    [Abstract] [Full Text] [Related]

  • 4. Right ventricular pacing is associated with impaired overall survival, but not with an increased incidence of ventricular tachyarrhythmias in routine cardioverter/defibrillator recipients with reservedly programmed pacing.
    Stockburger M, Celebi O, Krebs A, Knaus T, Nitardy A, Habedank D, Dietz R.
    Europace; 2009 Jul; 11(7):924-30. PubMed ID: 19447808
    [Abstract] [Full Text] [Related]

  • 5. Long-term follow-up of patients supplied with single-chamber or dual-chamber cardioverter defibrillators.
    Kolb C, Deisenhofer I, Schmieder S, Barthel P, Zrenner B, Karch MR, Schmitt C.
    Pacing Clin Electrophysiol; 2006 Sep; 29(9):946-52. PubMed ID: 16981917
    [Abstract] [Full Text] [Related]

  • 6. The effect of gender on mortality or appropriate shock in patients with nonischemic cardiomyopathy who have implantable cardioverter-defibrillators.
    Chen HA, Hsia HH, Vagelos R, Fowler M, Wang P, Al-Ahmad A.
    Pacing Clin Electrophysiol; 2007 Mar; 30(3):390-4. PubMed ID: 17367359
    [Abstract] [Full Text] [Related]

  • 7. Chronic renal insufficiency is an independent predictor of mortality in implantable cardioverter-defibrillator recipients.
    Chen-Scarabelli C, Scarabelli TM.
    Pacing Clin Electrophysiol; 2007 Mar; 30(3):371-6. PubMed ID: 17367356
    [Abstract] [Full Text] [Related]

  • 8. Long-term predictors of mortality in ICD patients with non-ischaemic cardiac disease: impact of renal function.
    Schefer T, Wolber T, Binggeli C, Holzmeister J, Brunckhorst C, Duru F.
    Europace; 2008 Sep; 10(9):1052-9. PubMed ID: 18687703
    [Abstract] [Full Text] [Related]

  • 9. Arrhythmic death in implantable cardioverter defibrillator patients: a long-term study over a 10 year implantation period.
    Duray GZ, Schmitt J, Richter S, Israel CW, Hohnloser SH.
    Europace; 2009 Nov; 11(11):1462-8. PubMed ID: 19797255
    [Abstract] [Full Text] [Related]

  • 10. Clinical predictors and prognostic significance of electrical storm in patients with implantable cardioverter defibrillators.
    Brigadeau F, Kouakam C, Klug D, Marquié C, Duhamel A, Mizon-Gérard F, Lacroix D, Kacet S.
    Eur Heart J; 2006 Mar; 27(6):700-7. PubMed ID: 16421175
    [Abstract] [Full Text] [Related]

  • 11. Mortality rates and clinical predictors of reduced survival after cardioverter defibrillator implantation.
    Thibodeau JB, Pillarisetti J, Khumri TM, Jones PG, Main ML.
    Am J Cardiol; 2008 Mar 15; 101(6):861-4. PubMed ID: 18328854
    [Abstract] [Full Text] [Related]

  • 12. Outcomes of subcutaneous implantable cardioverter-defibrillator implantation in patients on hemodialysis.
    Koman E, Gupta A, Subzposh F, Saltzman H, Kutalek SP.
    J Interv Card Electrophysiol; 2016 Mar 15; 45(2):219-23. PubMed ID: 26768264
    [Abstract] [Full Text] [Related]

  • 13. Clustering of ventricular tachyarrhythmias in heart failure patients implanted with a biventricular cardioverter defibrillator.
    Lunati M, Gasparini M, Bocchiardo M, Curnis A, Landolina M, Carboni A, Luzzi G, Zanotto G, Ravazzi P, Magenta G, Denaro A, Distefano P, Grammatico A, InSync ICD Italian Registry Investigators.
    J Cardiovasc Electrophysiol; 2006 Dec 15; 17(12):1299-306. PubMed ID: 17239095
    [Abstract] [Full Text] [Related]

  • 14. Benefit of primary prevention implantable cardioverter-defibrillators in the setting of chronic kidney disease: a decision model analysis.
    Amin MS, Fox AD, Kalahasty G, Shepard RK, Wood MA, Ellenbogen KA.
    J Cardiovasc Electrophysiol; 2008 Dec 15; 19(12):1275-80. PubMed ID: 18662180
    [Abstract] [Full Text] [Related]

  • 15. A clinical risk score to predict the time to first appropriate device therapy in recipients of implantable cardioverter defibrillators.
    Hreybe H, Saba S.
    Pacing Clin Electrophysiol; 2007 Mar 15; 30(3):385-9. PubMed ID: 17367358
    [Abstract] [Full Text] [Related]

  • 16. Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias.
    Healey JS, Hallstrom AP, Kuck KH, Nair G, Schron EP, Roberts RS, Morillo CA, Connolly SJ.
    Eur Heart J; 2007 Jul 15; 28(14):1746-9. PubMed ID: 17283003
    [Abstract] [Full Text] [Related]

  • 17. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.
    Koller MT, Schaer B, Wolbers M, Sticherling C, Bucher HC, Osswald S.
    Circulation; 2008 Apr 15; 117(15):1918-26. PubMed ID: 18391108
    [Abstract] [Full Text] [Related]

  • 18. Impact of renal dysfunction on appropriate therapy in implantable cardioverter defibrillator patients with non-ischaemic dilated cardiomyopathy.
    Takahashi A, Shiga T, Shoda M, Manaka T, Ejima K, Hagiwara N.
    Europace; 2009 Nov 15; 11(11):1476-82. PubMed ID: 19661116
    [Abstract] [Full Text] [Related]

  • 19. Renal insufficiency predicts the time to first appropriate defibrillator shock.
    Hreybe H, Ezzeddine R, Bedi M, Barrington W, Bazaz R, Ganz LI, Jain S, Ngwu O, London B, Saba S.
    Am Heart J; 2006 Apr 15; 151(4):852-6. PubMed ID: 16569548
    [Abstract] [Full Text] [Related]

  • 20. Outcomes of early risk stratification and targeted implantable cardioverter-defibrillator implantation after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Zaman S, Sivagangabalan G, Narayan A, Thiagalingam A, Ross DL, Kovoor P.
    Circulation; 2009 Jul 21; 120(3):194-200. PubMed ID: 19581496
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.